Home›Stock Screener›Satiate Agri

Satiate Agri Share Price Today | Stock Price & Satiate Agri Share Screener

SATAGRI Pharmaceuticals

Track the current Satiate Agri share price and stock price live with TickJournal's free stock screener. Check Satiate Agri 52-week for the annual price range and momentum. Use the Satiate Agri stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Satiate Agri opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹1 and net income of ₹-3, with EBITDA of ₹-3, an operating margin of -274.0% and a profit margin of -300.0%.

Satiate Agri Market Cap ₹8.40 Cr.
SATAGRI P/E Ratio (TTM) 15.00
Satiate Agri P/B Ratio -3.39
EPS (TTM) ₹-3.56
Dividend Yield -
Debt to Equity 54.38
SATAGRI 52 Week High -
Satiate Agri 52 Week Low -
Operating Margin -274.00%
Profit Margin -300.00%
SATAGRI Revenue (TTM) ₹1.00
EBITDA ₹-3.00
Net Income ₹-3.00
Total Assets ₹4.00
Total Equity ₹-1.00

Satiate Agri Share Price Chart

Track the current stock price of Satiate Agri with an interactive chart. Analyse SATAGRI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Satiate Agri stock quote in one place.

Satiate Agri Company Profile - Fundamental Screener

Screen Satiate Agri company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SATAGRI shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE06DM01015.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE06DM01015

Satiate Agri Balance Sheet Screener

Screen SATAGRI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹4 against total liabilities of ₹4, up from ₹1 in 2024.

Latest statistics put total assets at ₹4 and shareholder funds at ₹-1, with a leverage ratio of 54.38.

Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016

Assets

Total Assets 4 1 1 0 0 0 0 0 0 0
Current Assets 4 1 1 0 0 0 0 0 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 0

Liabilities

Total Liabilities 4 1 1 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity -1 1 1 0 0 0 0 0 0 0
Share Capital 3 3 3 3 3 3 3 3 3 3
Reserves & Surplus -3 -2 -2 -3 -3 -3 -3 -3 -3 -3

Satiate Agri Income Statement Screener - Profit & Revenue Analysis

Screen Satiate Agri income statement and profit fundamentals. Analyze SATAGRI quarterly results. Satiate Agri reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹1 and net profit was ₹-3, equal to earnings per unit of ₹-10.30, at an operating margin of -274%.

In that period expenses were ₹4, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹0 and net profit of ₹-1.

Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 1 0 0 92 0 0 0 0 0 0 0 0
Expenses 4 1 0 91 0 0 0 0 0 0 0 0

Operating Costs and Margins

EBITDA -3 -1 0 1 0 0 0 0 0 0 0 0
Operating Profit % -274.00% -1100.00% -58.00% 1.00% 6.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax -3 -1 0 1 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit -3 -1 0 1 0 0 0 0 0 0 0 0
EPS -10.30 -3.56 -0.04 0.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Satiate Agri Cash Flow Screener - Liquidity Fundamentals

Screen SATAGRI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities used ₹4.

Over the same period, investing activities provided ₹0 and financing activities provided ₹4.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March

Cash from Operations and Investing

Operating Activities -4 -1 1 0 0 0 0 0 0 0
Investing Activities 0 0 0 0 0 0 0 0 0 0

Financing and Net Cash

Financing Activities 4 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 -1 1 0 0 0 0 0 0 0

Satiate Agri Shareholding Pattern Screener

See Satiate Agri shareholding pattern with promoter, FII, and DII holdings. Check Satiate Agri promoter holding and ownership changes for SATAGRI on TickJournal, and see how institutional stock price moves affect the market.

In 2025-Mar, promoters held 53.82%, foreign institutions 0.00%, domestic institutions 0.00% and the public 37.97%, spread across 1,632 shareholders.

The shareholder count was 1,632 in 2025-Mar, compared with 1,664 in 2025-Jun.

Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar

Promoter Holding

Promoter Holding 53.82% 30.62% 30.62% 53.82% 53.82% 53.82% 53.82% 53.82%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 37.97% 41.30% 43.19% 37.97% 37.97% 37.97% 37.97% 37.97%
Other Holding 8.20% 28.08% 26.19% 8.20% 8.20% 8.20% 8.20% 8.20%
Shareholder Count 1,632 1,664 1,680 1,632 1,632 1,632 1,632 1,632

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Satiate Agri. Satiate Agri dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Satiate Agri.

Satiate Agri Stock Index Membership - Nifty & Sensex

See which indices include Satiate Agri stock. Check SATAGRI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Satiate Agri is not part of any tracked indices.
Only major market indices are tracked in our system.

Satiate Agri Market Events Screener - Corporate Actions

Get Satiate Agri corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Satiate Agri stock events that may affect SATAGRI share price, along with derivatives, futures and options activity and sector gainers.

8 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 13, 2025, with a record date of November 13, 2025.

It is followed by Annual General Meeting dated September 30, 2025 and Quarterly Result Announcement dated August 14, 2025.

Announcement Date Record Date Event Type Information Price Impact
2025-11-13 2025-11-13 Quarterly Result Announcement NA -4.98%
2025-09-30 2025-09-30 Annual General Meeting NA 0.00%
2025-08-14 2025-08-14 Quarterly Result Announcement NA 0.00%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 0.00%
2025-02-22 2025-02-22 Extraordinary General Meeting NA -44.09%
2024-11-13 2024-11-13 Quarterly Result Announcement NA 0.00%
2024-09-28 2024-09-28 Annual General Meeting NA 0.00%
2023-03-28 2023-03-28 Change Of Name NA -

Satiate Agri Competitors Screener - Peer Stocks Comparison

Screen SATAGRI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 430,873 40.68 54,729 9.71% 10,980 63.65
Divis Laboratories 169,913 69.05 9,712 18.67% 2,191 50.10
Torrent Pharmaceuticals 127,195 58.80 11,539 6.99% 1,911 60.01
Cipla 121,890 22.73 28,410 7.12% 5,291 48.01
Dr Reddys Laboratories 106,196 18.15 33,741 16.73% 5,725 61.42
Lupin 95,306 21.34 22,910 13.74% 3,306 67.65
Zydus Life Science 94,058 18.56 23,511 18.55% 4,615 40.18
Mankind Pharma 90,468 52.05 12,744 20.90% 2,007 32.30
Aurobindo Pharma 69,963 20.70 32,346 9.43% 3,484 58.88
Alkem Laboratories 67,829 28.29 13,458 3.70% 2,216 53.12

Satiate Agri Company Announcements - News & Reports Screener

Screen SATAGRI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 14, 2025.

The next most recent announcements are dated November 13, 2025 and November 13, 2025.

Date Update Actions
2025-11-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-13 Non Applicability Of RPT Provisions For The Quarter And Half Year Ended 30.09.2025. -
2025-11-13 Financial Results For The Quarter And Half Year Ended 30.09.2025. -
2025-11-13 Board Meeting Outcome for Outcome Of Board Meeting Held On 13.11.2025. -
2025-11-08 Board Meeting Intimation for Approval Of Un-Audited Standalone Financial Results For The Quarter And Half Year Ended September 30 2025. -
2025-10-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-10-01 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-10-01 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2025-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2025-09-25 Closure of Trading Window -
2025-09-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-09-09 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-09-09 Change In Authorisation Of Key Managerial Personnel Of The Company Authorised To Determine Materiality Of An Event Or Information For The Purpose Of Making Disclosure To The Stock Exchange -
2025-09-09 Board Meeting Outcome for Outcome Of Board Meeting Held On 09.09.2025. -
2025-09-06 Reg. 34 (1) Annual Report. -
2025-09-06 Submission Of Notice Of 38Th Annual General Meeting. -
2025-09-06 Intimation Of Book Closure For Annual General Meeting. -
2025-09-06 Announcement under Regulation 30 (LODR)-Change in Management -
2025-09-06 Board Meeting Outcome for Outcome Of Board Meeting Held On 06.09.2025 -
2025-09-03 Board Meeting Outcome for For Meeting Of Board Of Directors Held On 02.09.2025. -

Frequently Asked Questions

How is the company valued right now?

The P/E ratio is 15.00 and the P/B ratio is -3.39, with earnings per unit of ₹-3.56. Market capitalisation stands at ₹8.40 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.